Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

The coronavirus disease 2019 (COVID-19) pandemic is having a major clinical as well as organisational impact on the national health-care system in Italy, particularly in high-volume hospitals which are usually active for many essential clinical needs, including inflammatory bowel disease (IBD). Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Scaldaferri, Franco, Pugliese, Daniela, Privitera, Giuseppe, Onali, Sara, Lopetuso, Loris Riccardo, Rizzatti, Gianenrico, Settanni, Carlo Romano, Pizzoferrato, Marco, Schiavoni, Elisa, Turchini, Laura, Amatucci, Valeria, Napolitano, Daniele, Bernabei, Tiziana, Mora, Vincenzina, Laterza, Lucrezia, Papa, Alfredo, Guidi, Luisa, Rapaccini, Gian Lodovico, Gasbarrini, Antonio, Armuzzi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435006/
https://www.ncbi.nlm.nih.gov/pubmed/32438878
http://dx.doi.org/10.1177/2050640620929133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435006/
https://www.ncbi.nlm.nih.gov/pubmed/32438878
http://dx.doi.org/10.1177/2050640620929133

Ejemplares similares